Trelagliptin succinate powder Raw Materials CAS 1029877-94-8

Related Attributes

Product details

Uses and synthesis of Trelagliptin succinate powder

Trelagliptin succinate powder was developed by Takeda in Japan and launched in March 2015 under the brand name Zafatek for the treatment of type 2 diabetes. Trelagliptin succinate CAS 1029877-94-8 is a white to quasi-white crystalline or crystalline powder, readily soluble in water or dimethyl sulphone, slightly soluble in methanol, slightly soluble in ethanol (99.5), tetrahydrofuran or diethylamine, and very slightly soluble in acetonitrile or 2-propanol.

Applications/Functions of Trelagliptin succinate powder

1. Trelagliptin succinate Raw Materials are dipeptidyl peptidase Ⅳ(DPP-Ⅳ) inhibitors developed by Takeda(Takeda Pharmaceutical Co., LTD.) in Japan, which can selectively and continuously inhibit DPP-Ⅳ and control blood sugar levels.
2. Trelagliptin succinate powder has good safety and efficacy. Once a week, Trelagliptin succinate powder can effectively control the blood sugar level and improve the medication compliance of patients. Trelagliptin succinate CAS 1029877-94-8 is used in the treatment of diabetes mellitus.

Physicochemical Property of Trelagliptin succinate powder

Trelagliptin succinate Raw Materials are white to white crystalline or crystalline powders, readily soluble in water or dimethyl sulphone, slightly soluble in methanol, slightly soluble in ethanol (99.5), tetrahydrofuran or diethylamine, and very slightly soluble in acetonitrile or 2-propanol.

Production methodprocess of Trelagliptin succinate powder

Why choose us?

HRK Factory

About Shipping